Biotech company Argos raises $42.5 million in spite of tough market conditions

ArgosIn spite of the challenging climate to raise capital, a North Carolina biotech company raised $42.5 million for its kidney-focused cancer drug.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.